Mary Rozenman

Energizer
DISC Type : I

CFO and CBO at insitro

San Francisco Bay Area, United States

Overview

Mary Rozenman is the CFO and CBO of insitro, where she leads finance, corporate strategy, and business development. A Harvard Ph. D. graduate, she was a founding team member at Aimmune Therapeutics, which developed the first approved drug for peanut allergy and was acquired by Nestlé Health Sciences for $2. 6B.

Outside of work, Mary enjoys cooking, hiking, golf, and theater. She is passionate about mentoring and creating opportunities for women in the biotech industry, serving on the Lifescience Council for Springboard Enterprises to support women-led companies. She balances her career with her family, including her husband and two children.

Unique fact: She holds a B. A. from Columbia University in both Biochemistry and Russian Literature, showcasing her diverse intellectual interests beyond science.

Personality Overview

Full Of Energy

Imaginative

Relationship Oriented

Unlike C or D types, they are vocal with their opinions but not so much with their questions.  They are really good at seeing what the long-term impacts of their decisions could be. They are not always early adopters but can be pursuaded by leveraging strong relationships.

Topics They Care About

AI in Drug Discovery
At insitro, she is central to the mission of applying machine learning to biological data at scale to discover and develop medicines better, faster, and cheaper.
Biotech Corporate Strategy
Has raised over $1B in capital across her career and co-led the successful 2015 IPO for Aimmune Therapeutics, demonstrating deep expertise in strategic finance and partnerships.
Women in Biotech
Actively supports women-led companies as an advisor for Springboard Enterprises and advocates for bringing more women into C-suite and board roles in the biotech industry.

Media Appearances

Mary has no verified media appearances

Work History

8-2019
CFO and CBO at insitro
6-2021
Board Member at Tessera Therapeutics
4-2018 - 4-2021
Lifescience Council Member at Springboard Enterprises
9-2019 - 8-2020
Executive Women in Bio 2019 Board Room Ready Member at Women In Bio - Engage. Educate. Empower.
2-2016 - 7-2019
Senior Vice President, Corporate Development and Strategy at Aimmune Therapeutics

Education

9-2003 - 12-2007
Ph.D. from Harvard University
1999 - 2003
BA from Columbia College, Columbia University

More Information

Social Presence :

Prographics :

Exp : 9 Location : San Francisco Bay Area, United States Job Level : Leadership Designation : CFO and CBO at insitro
URL has been copied!

Insights For Selling To Mary

During A Call Or A Meeting

DO's

  • Talk about their team and how your product will help them do things better and easier
  • Use adjectives like ‘amazing’, ‘coolest’, ‘unbelievable’ etc.
  • Be friendly and entertaining in your conversation

DONT's

  • Don’t be too formal, focus on building comfort and trust
  • Don’t push them to make a decision too fast, let them get comfortable first
  • Don’t be excessively objective, be a storyteller

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Mary is

  • Relationship and rapport can play an important role, sometimes more than the other factors.
  • Will you ever get a clear answer from Mary

  • They will probably never say no directly, you have to make that decision yourself.

Insights For Deal Planning

    How fast (or slow) will Mary move?

  • They are not the quickest decision makers, their friendly attitude could be misleading.
  • Can Mary take some risk or not?

  • They may take certain risks that they deem unlikely of personal repercussions.

You And Mary

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.